Searchable abstracts of presentations at key conferences on calcified tissues

ba0003cu2.1 | Management of parathyroid diseases | ECTS2014

Hypoparathyroidism: diagnosis and management

Cusano Natalie

Hypoparathyroidism is a disorder characterized by hypocalcemia, low or absent parathyroid hormone (PTH), and abnormal bone remodeling. The diagnosis is made in the setting of hypocalcemia with markedly reduced or absent PTH levels. Postoperative hypoparathyroidism is the most common etiology. Other causes of hypoparathyroidism include autoimmune disease and rarely, congenital syndromes of parathyroid dysgenesis such as DiGeorge syndrome. Standard treatment of hypoparathyroidis...

ba0002p134 | (1) | ICCBH2013

Cessation of ambulation results in a dramatic loss of trabecular bone density in boys with Duchenne muscular dystrophy

Crabtree Nicola , Bebbington Natalie , Roper Helen , McMurchie Heather , Shaw Nicholas

Steroids are currently used to improve muscle strength and prolong ambulation in boys with Duchenne muscular dystrophy (DMD) although the effect on bone health is still unclear. The aim of this study was to compare bone strength in healthy children and boys with DMD and investigate the interaction between diminished muscle function, loss of ambulation and high dose oral steroids.Fifty children were studied, 14 healthy boys (HB), 13 boys with DMD who rema...

ba0005p231 | Energy metabolism and bone, fat and bone | ECTS2016

Osteocalcin transgenic mice reveal aspects of the bone/glucose axis, as well as powerful suppression of ectopic osteocalcin protein production

Horsnell Harry , Wee Natalie , Kulkarni Rishikesh , Herzog Herbert , Baldock Paul

Rationale: Mice deficient in osteocalcin show an impaired glucose tolerance, however, the exact mechanism involved have yet to be fully elucidated. We aimed to overexpress osteocalcin to determine its effect on glucose homeostasis and explore the signalling pathway involved. We wished to expand upon previous preliminary data suggesting that this pathway involve neuropeptide Y (NPY) signalling.Objective: To analyse the in vivo and in vitro</e...

ba0001pp224 | Cell biology: osteoclasts and bone resorption | ECTS2013

Polyunsaturated fatty acids and phytoestrogens modulate osteoclastogenesis and bone resorption in raw 264.7 macrophages

Shepherd Natalie , De Jager Cassandre , Kasonga Abe , Marais Sumari , Tousen Yuko , Kruger Marlena , Coetzee Magdalena

Osteoclasts are produced by fusion of pre-osteoclasts derived from stem cells of the monocyte/macrophage lineage in the presence of receptor activator of NF-κB ligand (RANKL) produced by osteoblasts. The phytoestrogens; genistein and daidzein, which are isoflavones found in Leguminosae such as soybeans, are currently being investigated for prevention of postmenopausal osteoporosis. Some polyunsaturated fatty acids (PUFAs) have been shown to exert a bone protectiv...

ba0002oc1 | Epidemiology | ICCBH2013

The Amalgamated Paediatric Bone Density Study (The ALPHABET Study): the collation and generation of UK based reference data for paediatric bone densitometry

Crabtree Nicola , Machin Mike , Bebbington Natalie , Adams Judith , Ahmed Faisal , Arundel Paul , Bishop Nicholas , Fewtrell Mary , Hogler Wolgang , Mughal M Zulf , Rhodes Laura , Shaw Nicholas , Ward Kate

Understanding normal patterns of bone growth is important for optimising bone health in children and reducing osteoporotic fractures in later life. Recently published guidelines for bone assessment in children state that to predict fractures a technique should identify children at risk of clinically significant fractures and that dual-energy absorptiometry (DXA) is the preferred method of assessment. Despite these guidelines there is still inconsistency and lack of consensus r...

ba0005p84 | Bone Matrix | ECTS2016

Anabolic parathyroid hormone (PTH) treatment does not alter periosteal bone mineral composition during primary and secondary mineralisation

Vrahnas Christina , Pearson Thomas A , Brunt Athena R , Forwood Mark R , Bambery Keith R , Tobin Mark J , John Martin T , Sims Natalie A

Parathyroid hormone (PTH) is used to stimulate bone formation in osteoporotic patients, however concerns have been raised about the quality of the matrix produced since lower levels of total matrix mineral have been reported in osteoporotic and fracture patients treated with PTH. High resolution synchrotron-based Fourier Transform Infrared Microscopy (sFTIRM) was used to determine mineral content in age-matched bone during anabolic PTH treatment, using the simplified lamellar ...

ba0007p9 | (1) | ICCBH2019

Do lifestyle factors play a role on bone health in boys diagnosed with Autism Spectrum Disorder? Preliminary data from the Promoting bone and gut health in our children (PROUD) study

Duckham Rachel L , Hyde Natalie K , Brennan-Olsen Sharon L , Hesketh Kylie , Teo Wei-Peng , Rodda Christine , Walsh Adam , Laing Emma M , Lewis Richard D

Objective: Autism Spectrum Disorder (ASD) is associated with lower bone mass in children. Physical activity and nutrition influence bone pathophysiology, and differences in these lifestyle factors are observed between children with vs. without ASD; however, whether these factors contribute to bone differences is unknown. We examined if: 1) differences existed in bone mineral density (BMD), content (BMC), or bone geometry in boys with vs without ASD and 2) whether physical acti...

ba0001pp206 | Cell biology: osteoblasts and bone formation | ECTS2013

Serum sclerostin does not reflect its expression in bone, but is related to bone mineral density

Bravenboer Nathalie , Visser Ruben , den Heijer Martin , Heijboer Annemieke

Sclerostin is a major negative regulator of osteoblastic activity. Serum sclerostin has a weak positive association with BMD but contradictory results have been described concerning associations with fractures. These contradictions could be explained by the fact that serum sclerostin does not reflect its action in bone. In this study we question whether serum sclerostin is associated with its expression in bone. In addition we aimed to detect associations between sclerostin in...

ba0003pp47 | Bone development/growth and fracture repair | ECTS2014

Mechanisms of action and osteogenic activity of bone marrow mesenchymal stromal cells are donor dependent

Leotot Julie , Lebouvier Angelique , Hernigou Philippe , Rouard Helene , Chevallier Nathalie

Human mesenchymal stromal cells (hMSC) have been investigated as a clinical therapy to promote tissue repair. However, the disappearance of grafted cells soon after engraftment suggests that hMSC could principally act as initiators of repair through paracrine mechanisms.The aim of this study was to evaluate the relative contribution of grafted hMSC and host cells in promoting bone tissue repair. We isolated hMSC from three bone marrow (BM) donors, then d...